Literature DB >> 8176961

Neutrophil-mediated acute lung injury after extracorporeal perfusion.

D Johnson1, D Thomson, T Hurst, K Prasad, T Wilson, F Murphy, A Saxena, I Mayers.   

Abstract

A pulmonary injury of varying severity occurs routinely after cardiopulmonary bypass. We studied the pulmonary complications of partial cardiopulmonary bypass in four groups of dogs to better define the injury and to evaluate the efficacy of two interventions (addition of a leukocyte filter or cyclooxygenase inhibition) on preservation of systemic oxygenation. All animals received a standard anesthetic (pentobarbital, morphine, and vecuronium) and, after sternotomy, three groups of animals received 3 hours of partial cardiopulmonary bypass. The animals were randomized to receive partial bypass alone (n = 6), indomethacin and bypass (n = 5), or a leukocyte filter and bypass (n = 5). A fourth group (n = 5) did not receive bypass and served as a time control. We measured blood gases and also obtained histologic samples to assess the degree of lung injury. We found that bypass alone caused a significant reduction (p < 0.05) in arterial oxygen tension 1 hour after the conclusion of bypass (175 +/- 53 mm Hg) compared with prebypass values (357 +/- 41 mm Hg). Pretreatment with indomethacin ameliorated the decrease in arterial oxygen tension from prebypass to postbypass values (477 +/- 50 mm Hg versus 339 +/- 57 mm Hg, respectively). Similarly use of a leukocyte filter reduced the decline in arterial oxygen tension from prebypass to postbypass values (440 +/- 71 mm Hg versus 311 +/- 73 mm Hg, respectively). We believe that indomethacin ameliorates the decline in systemic oxygenation associated with bypass by augmentation of hypoxic pulmonary vasoconstriction and that the leukocyte filter acted to reduce pulmonary edema and thereby minimized intrapulmonary shunt.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176961

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Kinetics of pro-inflammatory cytokines release in cardiac surgery with cardiopulmonary bypass.

Authors:  S Hirai; T Sueda; K Orihashi; M Watari; K Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

2.  Inhibition of matrix metalloproteinase-9 with low-dose doxycycline reduces acute lung injury induced by cardiopulmonary bypass.

Authors:  Chengxin Zhang; Wenhui Gong; Haiyuan Liu; Zhixiang Guo; Shenglin Ge
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  The impact of high-dose statin therapy on transendothelial neutrophil migration and serum cholesterol levels in healthy male volunteers.

Authors:  Aisling Kinsella; Adnan Raza; Susan Kennedy; Yue Fan; Alfred E Wood; R W Watson
Journal:  Eur J Clin Pharmacol       Date:  2011-06-08       Impact factor: 2.953

4.  Prolonged granulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children.

Authors:  E J Pesonen; R Korpela; M Leijala; H Sairanen; O M Pitkänen; K O Raivio; P Venge; S Andersson
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

5.  Isolated Human Pulmonary Artery Structure and Function Pre- and Post-Cardiopulmonary Bypass Surgery.

Authors:  Kim A Dora; Christopher P Stanley; Emad Al Jaaly; Francesca Fiorentino; Raimondo Ascione; Barnaby C Reeves; Gianni D Angelini
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

6.  Liver segment imaging using monocyte sequestration: a potential tool for fluorescence-guided liver surgery.

Authors:  Baifeng Qian; Daisuke Kyuno; Michael Schäfer; Wolfgang Gross; Arianeb Mehrabi; Eduard Ryschich
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

Review 7.  Efficacy and safety of noninvasive ventilation in patients after cardiothoracic surgery: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Guangfa Zhu; Yan Huang; Dong Wei; Yingxin Shi
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.